7 years of historical data (2018–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Aveanna Healthcare Holdings Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 58.2x P/FCF, 79% above the 5-year average of 32.5x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.5B | $899M | $509M | $145M | $1.4B | — | — | — |
| Enterprise Value | $3.0B | $2.3B | $2.0B | $1.5B | $2.6B | — | — | — |
| P/E Ratio → | -129.81 | — | — | — | — | — | — | — |
| P/S Ratio | 0.76 | 0.44 | 0.27 | 0.08 | 0.81 | — | — | — |
| P/B Ratio | — | — | — | — | 2.14 | — | — | — |
| P/FCF | 58.24 | 34.15 | 30.75 | — | — | — | — | — |
| P/OCF | 46.96 | 27.54 | 22.45 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Aveanna Healthcare Holdings Inc.'s enterprise value stands at 17.3x EBITDA, 47% below its 5-year average of 32.5x. The Healthcare sector median is 13.8x, placing the stock at a 25% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.14 | 1.04 | 0.83 | 1.57 | — | — | — |
| EV / EBITDA | 17.26 | 13.55 | 51.46 | — | — | — | — | — |
| EV / EBIT | 21.11 | 14.83 | 216.55 | — | — | — | — | — |
| EV / FCF | — | 88.02 | 118.65 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Aveanna Healthcare Holdings Inc. earns an operating margin of 6.9%. Operating margins have expanded from -35.9% to 6.9% over the past 3 years, signaling improving operational efficiency. ROIC of 8.0% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.4% | 31.4% | 31.4% | 30.9% | 32.3% | 30.4% | 30.3% | 31.5% |
| Operating Margin | 6.9% | 6.9% | 0.4% | -35.9% | -2.2% | -0.2% | 2.8% | 3.1% |
| Net Profit Margin | -0.5% | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% | -5.5% | -3.8% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | -208.9% | -25.9% | -21.2% | -24.8% | -13.7% |
| ROA | -0.7% | -0.7% | -8.1% | -32.7% | -5.6% | -3.3% | -4.9% | -3.0% |
| ROIC | 8.0% | 8.0% | 0.5% | -29.8% | -1.7% | -0.2% | 2.2% | 2.3% |
| ROCE | 11.1% | 11.1% | 0.6% | -38.1% | -2.0% | -0.2% | 2.8% | 2.9% |
Solvency and debt-coverage ratios — lower is generally safer
Aveanna Healthcare Holdings Inc. carries a Debt/EBITDA ratio of 8.8x, which is highly leveraged (183% above the sector average of 3.1x). Net debt stands at $1.4B ($1.5B total debt minus $84M cash). Interest coverage of just 0.9x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | 2.04 | 4.60 | 3.98 | 2.76 |
| Debt / EBITDA | 8.79 | 8.79 | 39.28 | — | — | 45.94 | 16.37 | 18.69 |
| Net Debt / Equity | — | — | — | — | 1.99 | 4.08 | 3.97 | 2.74 |
| Net Debt / EBITDA | 8.29 | 8.29 | 38.13 | — | — | 40.81 | 16.32 | 18.53 |
| Debt / FCF | — | 53.87 | 87.90 | — | — | 10.76 | — | 468.24 |
| Interest Coverage | 0.89 | 0.89 | 0.05 | -5.96 | -0.52 | -0.04 | 0.42 | 0.52 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.98x is below 1.0, meaning current liabilities exceed current assets. The current ratio has improved from 0.83x to 0.98x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | 0.98 | 0.89 | 0.83 | 0.81 | 1.31 | 1.11 | 1.08 |
| Quick Ratio | 0.98 | 0.98 | 0.89 | 0.83 | 0.81 | 1.31 | 1.11 | 1.08 |
| Cash Ratio | 0.21 | 0.21 | 0.12 | 0.06 | 0.09 | 0.53 | 0.02 | 0.04 |
| Asset Turnover | — | 1.22 | 1.17 | 1.04 | 0.72 | 0.81 | 0.88 | 0.81 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 50.06 | 47.34 | 46.07 | 48.99 | 44.16 | 43.33 | 53.12 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Aveanna Healthcare Holdings Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | 1.7% | 2.9% | 3.3% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $193M | $190M | $186M | $185M | $186M | $186M | $180M |
Compare AVAH with 5 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| AVAHYou | $2B | -129.8 | 17.3 | 58.2 | 31.4% | 6.9% | — | 8.0% | 8.8 |
| CHE | $6B | 22.3 | 17.3 | 17.8 | — | 13.4% | 25.3% | 23.8% | 0.4 |
| OPCH | $5B | 25.4 | 12.0 | 19.7 | 19.3% | 6.0% | 15.2% | 15.3% | — |
| ADUS | $2B | 19.9 | 13.2 | — | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 |
| EHAB | $686M | -4.4 | — | 14.5 | 48.7% | -11.1% | -24.9% | -7.3% | — |
| DCGO | $73M | 4.0 | 0.9 | 1.1 | 34.6% | 4.7% | 6.4% | 7.5% | 1.3 |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 7 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AVAH stacks up against sector leader Chemed Corporation.
Start ComparisonAveanna Healthcare Holdings Inc.'s current P/E ratio is -129.8x. This places it at the 50th percentile of its historical range.
Aveanna Healthcare Holdings Inc.'s current EV/EBITDA is 17.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 32.5x.
Based on historical data, Aveanna Healthcare Holdings Inc. is trading at a P/E of -129.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Aveanna Healthcare Holdings Inc. has 31.4% gross margin and 6.9% operating margin.
Aveanna Healthcare Holdings Inc.'s Debt/EBITDA ratio is 8.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.